Hemopatch ® as a primary dural sealant in cranial neurosurgery: Technical note and a retrospective study.

Homoud A AldahashMuhammad A AnsaryHana M HallakMeshari R AlhuthaylFaisal A Alotaibi

Published in: Neurosciences (Riyadh, Saudi Arabia) (2024)

as a dural sealant in cranial surgery is effective and safe. After supra-/infratentorial craniotomies, the rate of postoperative adverse events in our sample was within the range of known surgical revision rates. Future randomized clinical studies are required to confirm our encouraging findings.

Keyphrases

minimally invasive
total knee arthroplasty
double blind
coronary artery bypass
open label
patients undergoing
placebo controlled
phase iii
current status
total hip arthroplasty
phase ii
surgical site infection
clinical trial
randomized controlled trial
study protocol
acute coronary syndrome